Safety and efficacy of combined ezetimibe/simvastatin treatment and simvastatin monotherapy in patients with non-alcoholic fatty liver disease.

@article{Abel2009SafetyAE,
  title={Safety and efficacy of combined ezetimibe/simvastatin treatment and simvastatin monotherapy in patients with non-alcoholic fatty liver disease.},
  author={Tatj{\'a}na Abel and J{\'a}nos F{\'e}her and Elek Dinya and Mohamed Gamal Eldin and Attila Kov{\'a}cs},
  journal={Medical science monitor : international medical journal of experimental and clinical research},
  year={2009},
  volume={15 12},
  pages={MS6-11}
}
BACKGROUND Non-alcoholic fatty liver disease (NAFLD) is one of the most common chronic liver diseases all over the world. In patients with a high cardiovascular risk the decrease of cholesterol level is especially important. The primary goal of this study is to observe the safety and efficacy of combined ezetimibe / simvastatin treatment and simvastatin monotherapy in patients with NAFLD and high cardiovascular risk disease. The secondary goal of this investigation was to compare the safety and… CONTINUE READING